BSE Live
Oct 21, 14:55Prev. Close
1600.20
Open Price
1629.35
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Oct 21, 14:57Prev. Close
1602.60
Open Price
1585.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
Key Financial Ratios of Eris Lifesciences (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
Per Share Ratios | ||||||
Basic EPS (Rs.) | 25.85 | 28.82 | 28.10 | 29.89 | 26.16 | |
Diluted EPS (Rs.) | 25.81 | 28.79 | 28.07 | 29.88 | 26.14 | |
Cash EPS (Rs.) | 50.67 | 42.61 | 36.12 | 34.61 | 29.32 | |
Book Value [ExclRevalReserve]/Share (Rs.) | 209.57 | 190.11 | 163.30 | 140.35 | 116.10 | |
Book Value [InclRevalReserve]/Share (Rs.) | 209.57 | 190.11 | 163.30 | 140.35 | 116.10 | |
Revenue from Operations/Share (Rs.) | 212.46 | 147.70 | 123.92 | 99.10 | 89.25 | |
PBDIT/Share (Rs.) | 76.03 | 51.36 | 40.29 | 37.60 | 32.35 | |
PBIT/Share (Rs.) | 52.87 | 37.94 | 31.68 | 32.84 | 29.19 | |
PBT/Share (Rs.) | 35.89 | 31.70 | 29.76 | 32.53 | 29.05 | |
Net Profit/Share (Rs.) | 27.50 | 29.19 | 27.51 | 29.85 | 26.16 | |
NP After MI And SOA / Share (Rs.) | 25.83 | 28.82 | 28.10 | 29.88 | 26.16 | |
Profitability Ratios | ||||||
PBDIT Margin (%) | 35.78 | 34.77 | 32.51 | 37.93 | 36.24 | |
PBIT Margin (%) | 24.88 | 25.68 | 25.56 | 33.13 | 32.70 | |
PBT Margin (%) | 16.89 | 21.46 | 24.01 | 32.82 | 32.55 | |
Net Profit Margin (%) | 12.94 | 19.76 | 22.20 | 30.12 | 29.30 | |
NP After MI And SOA Margin (%) | 12.15 | 19.50 | 22.67 | 30.14 | 29.30 | |
Return on Networth/Equity (%) | 12.32 | 15.15 | 17.40 | 21.28 | 22.52 | |
Return on Capital Employed (%) | 12.74 | 11.42 | 13.36 | 21.53 | 23.76 | |
Return on Assets (%) | 5.00 | 5.56 | 10.42 | 17.87 | 19.35 | |
Total Debt/Equity (X) | 0.85 | 1.06 | 0.38 | 0.02 | 0.00 | |
Asset Turnover Ratio (%) | 0.41 | 0.37 | 0.53 | 0.61 | 66.04 | |
Liquidity Ratios | ||||||
Current Ratio (X) | 0.89 | 0.91 | 1.73 | 3.14 | 2.80 | |
Quick Ratio (X) | 0.64 | 0.83 | 1.43 | 2.55 | 2.23 | |
Inventory Turnover Ratio (X) | 1.06 | 1.11 | 1.26 | 1.31 | 12.83 | |
Dividend Payout Ratio (NP) (%) | 28.43 | 0.00 | 26.15 | 20.10 | 21.02 | |
Dividend Payout Ratio (CP) (%) | 14.99 | 0.00 | 20.01 | 17.34 | 18.75 | |
Earnings Retention Ratio (%) | 71.57 | 0.00 | 73.85 | 79.90 | 78.98 | |
Cash Earnings Retention Ratio (%) | 85.01 | 0.00 | 79.99 | 82.66 | 81.25 | |
Coverage Ratios | ||||||
Interest Coverage Ratios (%) | 4.48 | 8.24 | 20.94 | 123.26 | 219.92 | |
Interest Coverage Ratios (Post Tax) (%) | 4.48 | 8.24 | 20.94 | 123.26 | 219.92 | |
Valuation Ratios | ||||||
Enterprise Value (Cr.) | 21,908.96 | 13,413.39 | 8,575.56 | 9,359.51 | 8,168.96 | |
EV/Net Operating Revenue (X) | 7.57 | 6.68 | 5.09 | 6.95 | 6.74 | |
EV/EBITDA (X) | 21.16 | 19.20 | 15.65 | 18.31 | 18.60 | |
MarketCap/Net Operating Revenue (X) | 6.67 | 5.70 | 4.62 | 6.95 | 6.77 | |
Retention Ratios (%) | 71.56 | 0.00 | 73.84 | 79.89 | 78.97 | |
Price/BV (X) | 6.76 | 4.42 | 3.54 | 4.91 | 5.21 | |
Price/Net Operating Revenue | 6.67 | 5.70 | 4.62 | 6.95 | 6.77 | |
Earnings Yield | 0.02 | 0.03 | 0.05 | 0.04 | 0.04 |
25.08.2025
12.08.2025
Eris Life Consolidated June 2025 Net Sales at Rs 773.00 crore, up 7.4% Y-o-Y
08.08.2025
06.08.2025
Buy Eris Lifesciences; target of Rs 1975: Prabhudas Lilladher
12.08.2025
Eris Life Consolidated June 2025 Net Sales at Rs 773.00 crore, up 7.4% Y-o-Y
05.08.2025
Eris Life Standalone June 2025 Net Sales at Rs 578.64 crore, up 26.7% Y-o-Y
20.05.2025
Eris Life Consolidated March 2025 Net Sales at Rs 705.30 crore, up 28.02% Y-o-Y
20.05.2025
Eris Life Standalone March 2025 Net Sales at Rs 404.77 crore, up 18.6% Y-o-Y
17.01.2023
Eris Lifesciences Q3 PAT seen up 7.2% YoY to Rs 1,080 cr: Nirmal Bang
08.07.2022
Eris Lifesciences Q1 PAT seen up 4.3% YoY to Rs 111.3 cr: Prabhudas Lilladher
14.04.2022
Eris Lifesciences Q4 PAT seen up 30.7% YoY to Rs 89.2 cr: Prabhudas Lilladher
13.01.2022
Eris Lifesciences Q3 PAT seen up 12.4% YoY to Rs 101.4 cr: Prabhudas Lilladher